QuantuMDx Scales Up to Mass Manufacture Q-POC
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read MorePosted by Melanie Hamilton-Basich | Jan 12, 2021 | Covid 19, Flu & Respiratory Infections, POC Rapid Assays |
QuantuMDx expects to achieve CE-IVD marking for its Q-POC system in early 2021, following a release for research use only.
Read MorePosted by Laurie Bonner | Jan 12, 2021 | Covid 19, Immunoassay |
Independently validated early results have proven 100% in specificity after testing 280 samples and 100% sensitivity by testing 260 samples of recovered and symptomatic patients.
Read MorePosted by Melanie Hamilton-Basich | Jan 11, 2021 | Cancer, Digital Imaging |
With Concentriq, LabPON gains added flexibility to scale its routine digital pathology operations as the total number of worldwide cancer cases continues to rise.
Read MorePosted by Melanie Hamilton-Basich | Jan 8, 2021 | Covid 19, Research |
University of Birmingham Enterprise has filed a patent application covering the method and its use in diagnostic equipment, and is now seeking to license the patent for rapid product development.
Read MorePosted by Melanie Hamilton-Basich | Jan 8, 2021 | Covid 19 |
Funding will provide critical support for covid-19 testing and vaccination-related activities to jurisdictions before January 19, 2021.
Read More